Evaluation of namoxyrate in the treatment of geriatric arthritics.
D000368:Aged; D000700:Analgesics / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001168:Arthritis / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002087:Butyrates / Q000009:adverse effects; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009269:Nalorphine / Q000494:pharmacology; D010003:Osteoarthritis / Q000188:drug therapy*; D010919:Placebos
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D002087:Butyrates; D010919:Placebos; D009269:Nalorphine